Study explorer (study characteristics and results) method abbreviations pdf   xlsx

display ongoing studies
Study Ref. Design studied treatmentcontrol treatmentpatientsstudy risk of biassample sizes Results

COVID 19 outpatients meta-analysis

RCTdiscontinuation of ACEI/ARBcontinuation of ACEI/ARBCOVID 19 outpatientssome concern
104/100 inconclusive
    University of Minnesota
    RCTangiotensin receptor blockers (ARBs)placeboCOVID 19 outpatientssome concern
    58/59 inconclusive
    • inconclusive 2.2-fold increase in hospitalization (PE) with a moderate degree of certainty due to some concern in risk of bias

    PE: primary endpoint; (a): to be demonstrated a result must be statistically significant on a primary endpoint (with multiplicity adjustment if necessary);
    Study risk of bias assessed for the study primary endpoint(s) or the main endpoints in case of no formally defined primary endpoint(s).